1. Home
  2. Analysis
  3. Risedronate-sodium
  4. Azilect

Risedronate sodium and Azilect drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 6 people who take Risedronate sodium and Azilect. Common interactions include convulsion among females, and confusional state among males.

The phase IV clinical study analyzes what interactions people who take Risedronate sodium and Azilect have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 25, 2023

6 people who take Risedronate sodium and Azilect together, and have interactions are studied.

What is Risedronate sodium?

Risedronate sodium has active ingredients of risedronate sodium. It is used in osteoporosis. Currently, eHealthMe is studying from 12,223 Risedronate sodium users.

What is Azilect?

Azilect has active ingredients of rasagiline mesylate. It is used in parkinson's disease. Currently, eHealthMe is studying from 8,373 Azilect users.

Number of Risedronate sodium and Azilect reports submitted per year:

Risedronate sodium and Azilect drug interactions.

Common Risedronate Sodium and Azilect drug interactions by gender *:

female:

  1. Convulsion
  2. Movement disorder
  3. Blood pressure increased
  4. Headache
  5. Heart rate increased
  6. Nausea

male:

  1. Confusional state
  2. Disorientation
  3. Dyskinesia
  4. Jaw disorder
  5. Seizure
  6. Somnolence

Common Risedronate Sodium and Azilect drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Blood pressure increased
  2. Headache
  3. Heart rate increased
  4. Nausea
  5. Convulsion

60+:

  1. Confusional state
  2. Disorientation
  3. Dyskinesia
  4. Seizure

* Approximation only. Some reports may have incomplete information.

Do you take Risedronate sodium and Azilect?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Risedronate sodium side effects:

Browse all side effects of Risedronate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Azilect side effects:

Browse all side effects of Azilect:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Risedronate sodium interactions:

Browse all interactions between Risedronate sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Azilect interactions:

Browse all interactions between Azilect and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on risedronate sodium and rasagiline mesylate (the active ingredients of Risedronate sodium and Azilect, respectively), and Risedronate sodium and Azilect (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Risedronate sodium and Azilect.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.